(NASDAQ: FEMY) Femasys's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 27.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 43.33%.
Femasys's earnings in 2025 is -$21,113,957.On average, 5 Wall Street analysts forecast FEMY's earnings for 2025 to be -$16,392,963, with the lowest FEMY earnings forecast at -$15,750,102, and the highest FEMY earnings forecast at -$16,875,109. On average, 4 Wall Street analysts forecast FEMY's earnings for 2026 to be -$8,057,558, with the lowest FEMY earnings forecast at -$7,741,575, and the highest FEMY earnings forecast at -$8,294,545.
In 2027, FEMY is forecast to generate -$6,390,477 in earnings, with the lowest earnings forecast at -$6,139,870 and the highest earnings forecast at -$6,578,432.